Clairity Breast is the first FDA-authorized AI platform that predicts a woman’s five-year future risk of developing breast cancer, using only her existing screening mammogram.
“For more than 60 years, mammograms have saved lives by detecting early-stage cancers. Now, advancements in AI and computer vision can uncover hidden clues in the mammograms – invisible to the human eye – to help predict future risk. By delivering validated, equitable risk assessments, we can help expand access to life-saving early detection and prevention for women everywhere.”
Dr. Connie Lehman
AI is beginning to narrow a critical gap in breast cancer care. In February, Beth Israel Deaconess Medical Center (BIDMC) became the first medical center in the country to offer a new tool that uses artificial intelligence, coupled with a routine mammogram, to measure a patient’s future risk of breast cancer.
New guidelines from the National Comprehensive Cancer Network® champion artificial intelligence in breast cancer screening
Clairity is launching soon at health systems across the USA. Sign up to be notified when it’s available at a health system near you.
